IBUPROFEN SODIUM

IBUPROFEN SODIUM was reported 43007 times

These side effects are most commonly reported by patients taking IBUPROFEN SODIUM:

# Side effect Count
0 DRUG INEFFECTIVE 6911
1 NAUSEA 2770
2 FATIGUE 2748
3 HEADACHE 2615
4 PAIN 2518
5 DIARRHOEA 1824
6 PRODUCT USE IN UNAPPROVED INDICATION 1808
7 DIZZINESS 1769
8 ARTHRALGIA 1701
9 OFF LABEL USE 1527
10 DYSPNOEA 1462
11 VOMITING 1414
12 MALAISE 1366
13 ABDOMINAL DISCOMFORT 1318
14 RASH 1273
15 PAIN IN EXTREMITY 1209
16 PRURITUS 1194
17 ABDOMINAL PAIN UPPER 1185
18 INSOMNIA 1114
19 CONDITION AGGRAVATED 1108
20 ASTHENIA 1090
21 ANXIETY 1074
22 FEELING ABNORMAL 1046
23 BACK PAIN 1020
24 DRUG HYPERSENSITIVITY 1013
25 PYREXIA 983
26 COUGH 975
27 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 939
28 FALL 875
29 DEPRESSION 863
30 HYPERSENSITIVITY 859
31 NASOPHARYNGITIS 825
32 WEIGHT DECREASED 817
33 CONSTIPATION 796
34 SOMNOLENCE 773
35 GAIT DISTURBANCE 763
36 ABDOMINAL PAIN 756
37 DYSPEPSIA 756
38 URTICARIA 745
39 MUSCLE SPASMS 744
40 CHEST PAIN 739
41 WEIGHT INCREASED 721
42 HYPERTENSION 720
43 PRODUCT USE ISSUE 705
44 HYPOAESTHESIA 704
45 PERIPHERAL SWELLING 694
46 BLOOD PRESSURE INCREASED 686
47 JOINT SWELLING 655
48 PARAESTHESIA 647
49 HYPERHIDROSIS 644
50 SINUSITIS 635
51 INTENTIONAL PRODUCT MISUSE 629
52 DECREASED APPETITE 625
53 PNEUMONIA 613
54 MYALGIA 608
55 COVID-19 585
56 RHEUMATOID ARTHRITIS 575
57 MIGRAINE 554
58 ALOPECIA 547
59 ERYTHEMA 542
60 DRUG EFFECT INCOMPLETE 537
61 INCORRECT DOSE ADMINISTERED 535
62 MUSCULOSKELETAL STIFFNESS 529
63 OVERDOSE 523
64 PRODUCT DOSE OMISSION ISSUE 516
65 OROPHARYNGEAL PAIN 506
66 DYSPHAGIA 498
67 INJECTION SITE PAIN 496
68 URINARY TRACT INFECTION 495
69 TREMOR 477
70 DRUG INTOLERANCE 465
71 DYSGEUSIA 448
72 INTENTIONAL PRODUCT USE ISSUE 447
73 SWELLING 443
74 DEATH 438
75 THROAT IRRITATION 433
76 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 431
77 ARTHRITIS 421
78 MEMORY IMPAIRMENT 420
79 VISION BLURRED 413
80 HEART RATE INCREASED 409
81 MUSCULAR WEAKNESS 403
82 CONTUSION 402
83 PALPITATIONS 399
84 CONFUSIONAL STATE 398
85 CHILLS 397
86 FLUSHING 395
87 INFECTION 395
88 ANAEMIA 392
89 INJURY 391
90 GASTROINTESTINAL DISORDER 384
91 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 383
92 INFLUENZA 380
93 DRY MOUTH 372
94 INFLUENZA LIKE ILLNESS 372
95 THERAPEUTIC RESPONSE UNEXPECTED 367
96 HYPOTENSION 366
97 ABDOMINAL DISTENSION 364
98 OEDEMA PERIPHERAL 363
99 SWELLING FACE 360
100 POOR QUALITY DRUG ADMINISTERED 358
101 GASTROOESOPHAGEAL REFLUX DISEASE 353
102 CHEST DISCOMFORT 348
103 ASTHMA 347
104 BALANCE DISORDER 340
105 NEPHROLITHIASIS 340
106 DISCOMFORT 336
107 SLEEP DISORDER 336
108 MUSCULOSKELETAL PAIN 332
109 MOBILITY DECREASED 328
110 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327
111 RENAL FAILURE 326
112 DEHYDRATION 325
113 PRODUCT QUALITY ISSUE 323
114 CEREBROVASCULAR ACCIDENT 321
115 BURNING SENSATION 320
116 ARTHROPATHY 318
117 MYOCARDIAL INFARCTION 318
118 NIGHTMARE 317
119 HOT FLUSH 315
120 GASTRIC DISORDER 311
121 GENERAL PHYSICAL HEALTH DETERIORATION 311
122 NECK PAIN 306
123 STRESS 306
124 ILLNESS 303
125 WHITE BLOOD CELL COUNT DECREASED 300
126 INFLAMMATION 297
127 DRY SKIN 295
128 PULMONARY EMBOLISM 295
129 INFUSION RELATED REACTION 294
130 PSORIASIS 294
131 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 294
132 VISUAL IMPAIRMENT 287
133 STOMATITIS 286
134 BRONCHITIS 284
135 EMOTIONAL DISTRESS 283
136 FEELING HOT 280
137 SEDATION 275
138 ACUTE KIDNEY INJURY 272
139 PRODUCT PHYSICAL ISSUE 271
140 BLOOD CHOLESTEROL INCREASED 269
141 RHINORRHOEA 266
142 LOSS OF CONSCIOUSNESS 261
143 NEUROPATHY PERIPHERAL 257
144 HAEMOGLOBIN DECREASED 255
145 DEEP VEIN THROMBOSIS 254
146 DRUG DOSE OMISSION 252
147 HEPATIC ENZYME INCREASED 249
148 INJECTION SITE ERYTHEMA 249
149 BLISTER 244
150 BLOOD GLUCOSE INCREASED 242
151 EPISTAXIS 239
152 PRODUCT TASTE ABNORMAL 238
153 CHRONIC KIDNEY DISEASE 237
154 FLATULENCE 237
155 RENAL DISORDER 237
156 OSTEOARTHRITIS 236
157 GASTROINTESTINAL HAEMORRHAGE 234
158 MULTIPLE SCLEROSIS RELAPSE 229
159 GLOSSODYNIA 228
160 HAEMORRHAGE 228
161 PLATELET COUNT DECREASED 227
162 DRUG INTERACTION 223
163 EYE PAIN 223
164 EYE SWELLING 223
165 LIVER DISORDER 223
166 DRUG EFFECT DECREASED 222
167 SUICIDAL IDEATION 221
168 WHEEZING 220
169 AMNESIA 219
170 NASAL CONGESTION 215
171 BONE PAIN 214
172 HAEMATOCHEZIA 212
173 PSORIATIC ARTHROPATHY 211
174 TINNITUS 211
175 EXPIRED PRODUCT ADMINISTERED 210
176 NIGHT SWEATS 208
177 LIP SWELLING 206
178 SYNCOPE 206
179 IRRITABLE BOWEL SYNDROME 205
180 ILL-DEFINED DISORDER 204
181 VERTIGO 202
182 LOWER RESPIRATORY TRACT INFECTION 201
183 ORAL DISCOMFORT 200
184 LUNG DISORDER 199
185 MATERNAL EXPOSURE DURING PREGNANCY 199
186 UPPER RESPIRATORY TRACT INFECTION 196
187 NERVOUSNESS 195
188 RECTAL HAEMORRHAGE 194
189 UNEVALUABLE EVENT 192
190 SKIN EXFOLIATION 191
191 GAIT INABILITY 190
192 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 190
193 EAR INFECTION 187
194 ROAD TRAFFIC ACCIDENT 187
195 THROMBOSIS 184
196 PRODUCTIVE COUGH 183
197 CARDIAC DISORDER 182
198 COLITIS ULCERATIVE 181
199 IMPAIRED HEALING 181
200 CONTRAINDICATED PRODUCT ADMINISTERED 180
201 DRY EYE 177
202 DISEASE RECURRENCE 176
203 GASTRIC ULCER 175
204 SEIZURE 174
205 TREATMENT FAILURE 174
206 FOREIGN BODY 172
207 INJECTION SITE BRUISING 169
208 DISEASE PROGRESSION 168
209 THERAPEUTIC PRODUCT EFFECT DECREASED 168
210 NEUTROPENIA 167
211 ADVERSE DRUG REACTION 166
212 CATARACT 166
213 SCIATICA 165
214 ANAPHYLACTIC REACTION 164
215 EXTRA DOSE ADMINISTERED 164
216 RASH PRURITIC 164
217 RENAL FAILURE ACUTE 163
218 DYSPHONIA 162
219 CELLULITIS 161
220 HERPES ZOSTER 161
221 MULTIPLE SCLEROSIS 161
222 TACHYCARDIA 160
223 ACNE 157
224 OSTEOPOROSIS 157
225 PANIC ATTACK 155
226 CROHN^S DISEASE 154
227 OEDEMA 154
228 DYSURIA 153
229 INTENTIONAL OVERDOSE 152
230 DEPRESSED MOOD 150
231 DISTURBANCE IN ATTENTION 150
232 FIBROMYALGIA 150
233 ATRIAL FIBRILLATION 149
234 POLLAKIURIA 149
235 DRUG EFFECT LESS THAN EXPECTED 148
236 IRRITABILITY 148
237 SKIN DISCOLOURATION 148
238 SYNOVITIS 147
239 THROAT TIGHTNESS 147
240 THROMBOCYTOPENIA 147
241 ALANINE AMINOTRANSFERASE INCREASED 146
242 CHOKING 146
243 DRUG EFFECT DELAYED 146
244 HYPOAESTHESIA ORAL 146
245 JOINT RANGE OF MOTION DECREASED 146
246 BLOOD PRESSURE DECREASED 144
247 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 144
248 OXYGEN SATURATION DECREASED 142
249 PRODUCT SUBSTITUTION ISSUE 142
250 INJECTION SITE REACTION 141
251 PRODUCT USE COMPLAINT 141
252 HALLUCINATION 140
253 JOINT STIFFNESS 140
254 HEART RATE DECREASED 139
255 SPEECH DISORDER 139
256 GASTRITIS 138
257 INJECTION SITE SWELLING 138
258 RASH ERYTHEMATOUS 138
259 WHITE BLOOD CELL COUNT INCREASED 138
260 AGITATION 137
261 AUTOIMMUNE DISORDER 134
262 CHOLELITHIASIS 134
263 DIABETES MELLITUS 134
264 LETHARGY 134
265 LYMPHADENOPATHY 134
266 BLOOD PRESSURE FLUCTUATION 133
267 LIMB INJURY 133
268 LOWER LIMB FRACTURE 132
269 TYPE 2 DIABETES MELLITUS 132
270 FREQUENT BOWEL MOVEMENTS 131
271 SKIN BURNING SENSATION 130
272 ADVERSE EVENT 129
273 BURSITIS 129
274 INJECTION SITE HAEMORRHAGE 127
275 DRUG DEPENDENCE 126
276 EYE IRRITATION 126
277 INJECTION SITE PRURITUS 126
278 SEPSIS 126
279 PLEURAL EFFUSION 125
280 SYSTEMIC LUPUS ERYTHEMATOSUS 125
281 WOUND 125
282 OCULAR HYPERAEMIA 124
283 RASH MACULAR 122
284 VIRAL INFECTION 122
285 LIVER INJURY 120
286 SWOLLEN TONGUE 120
287 EYE DISORDER 119
288 SUICIDE ATTEMPT 119
289 EAR PAIN 118
290 PANCREATITIS 118
291 THERAPY CESSATION 118
292 DUODENAL ULCER PERFORATION 116
293 LIP DRY 116
294 CONVULSION 115
295 CORONARY ARTERY DISEASE 113
296 MEDICATION ERROR 113
297 THERAPY NON-RESPONDER 113
298 DYSPNOEA EXERTIONAL 112
299 DYSSTASIA 112
300 FAECES DISCOLOURED 112
301 COELIAC DISEASE 111
302 FLUID RETENTION 111
303 LIMB DISCOMFORT 111
304 MUSCLE INJURY 111
305 PRODUCT DOSE OMISSION 111
306 THERAPEUTIC RESPONSE DECREASED 110
307 CRYING 109
308 LABORATORY TEST ABNORMAL 109
309 MIDDLE INSOMNIA 109
310 GASTRIC HAEMORRHAGE 108
311 RENAL IMPAIRMENT 108
312 SKIN DISORDER 108
313 SURGERY 108
314 THERAPY INTERRUPTED 108
315 ULCER 108
316 POOR QUALITY SLEEP 107
317 SINUS DISORDER 107
318 ANKYLOSING SPONDYLITIS 106
319 COGNITIVE DISORDER 106
320 CYSTITIS 106
321 ECZEMA 106
322 ORAL PAIN 106
323 WRONG TECHNIQUE IN DRUG USAGE PROCESS 106
324 FUNGAL INFECTION 105
325 PRE-EXISTING CONDITION IMPROVED 105
326 C-REACTIVE PROTEIN INCREASED 104
327 HAEMATEMESIS 104
328 HOSPITALISATION 104
329 UNDERDOSE 104
330 ASPARTATE AMINOTRANSFERASE INCREASED 103
331 BLOOD PRESSURE SYSTOLIC INCREASED 103
332 EXOSTOSIS 103
333 FEELING COLD 103
334 GRIP STRENGTH DECREASED 103
335 HAND DEFORMITY 103
336 HELICOBACTER INFECTION 103
337 HYPOKALAEMIA 103
338 MOVEMENT DISORDER 103
339 BLOOD CREATININE INCREASED 102
340 INTERVERTEBRAL DISC PROTRUSION 102
341 TRANSIENT ISCHAEMIC ATTACK 102
342 ACCIDENTAL EXPOSURE TO PRODUCT 101
343 C-REACTIVE PROTEIN ABNORMAL 101
344 FOLLICULITIS 101
345 NEURALGIA 101
346 SNEEZING 101
347 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 99
348 ANHEDONIA 97
349 PAIN IN JAW 97
350 PRODUCT COMPLAINT 97
351 DELIRIUM 96
352 HYPERSOMNIA 96
353 OBESITY 96
354 RETCHING 96
355 NO ADVERSE EVENT 95
356 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94
357 LOCALISED INFECTION 94
358 POOR QUALITY PRODUCT ADMINISTERED 94
359 RASH GENERALISED 94
360 SEASONAL ALLERGY 94
361 WITHDRAWAL SYNDROME 94
362 FEAR 93
363 MALIGNANT NEOPLASM PROGRESSION 93
364 PRESCRIBED OVERDOSE 93
365 THERAPEUTIC RESPONSE SHORTENED 93
366 FACET JOINT SYNDROME 92
367 FEELING JITTERY 92
368 HYPOACUSIS 92
369 LACRIMATION INCREASED 92
370 URINARY RETENTION 92
371 CARDIAC FAILURE CONGESTIVE 91
372 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 90
373 MOOD SWINGS 89
374 PRODUCT ODOUR ABNORMAL 89
375 RASH PAPULAR 89
376 RIB FRACTURE 89
377 TOOTH DISORDER 89
378 CHOLECYSTITIS CHRONIC 88
379 FOOT DEFORMITY 88
380 PERICARDITIS 88
381 ACCIDENTAL OVERDOSE 87
382 MUSCULOSKELETAL DISCOMFORT 87
383 MUSCULOSKELETAL DISORDER 87
384 PEMPHIGUS 87
385 RESPIRATORY DISORDER 87
386 TOXICITY TO VARIOUS AGENTS 87
387 BONE DISORDER 86
388 DYSARTHRIA 86
389 HYPONATRAEMIA 86
390 RHEUMATIC FEVER 86
391 URINARY INCONTINENCE 86
392 EYE PRURITUS 85
393 HEAD INJURY 85
394 JOINT INJURY 85
395 RED BLOOD CELL COUNT DECREASED 85
396 RHEUMATOID FACTOR POSITIVE 85
397 WOUND INFECTION 85
398 ANGINA PECTORIS 84
399 DRUG WITHDRAWAL SYNDROME 84
400 EXPOSURE DURING PREGNANCY 84
401 HYPERCHOLESTEROLAEMIA 84
402 PHARYNGEAL OEDEMA 84
403 PRODUCT SIZE ISSUE 84
404 RESPIRATORY FAILURE 84
405 TOOTHACHE 84
406 BLINDNESS 83
407 PRODUCT COATING ISSUE 83
408 ANGER 82
409 DEEP VEIN THROMBOSIS POSTOPERATIVE 82
410 SKIN IRRITATION 82
411 CHROMATURIA 81
412 HYPOTHYROIDISM 81
413 ABNORMAL DREAMS 80
414 BLOOD URINE PRESENT 80
415 HEPATITIS 80
416 IMPAIRED WORK ABILITY 80
417 INTERVERTEBRAL DISC DEGENERATION 80
418 LARYNGITIS 80
419 MENTAL DISORDER 80
420 MUSCULOSKELETAL CHEST PAIN 80
421 PRURITUS GENERALISED 80
422 SCAR 80
423 HEAD DISCOMFORT 79
424 ORAL HERPES 79
425 SKIN PAPILLOMA 79
426 BODY HEIGHT DECREASED 78
427 DIPLOPIA 78
428 DISORIENTATION 78
429 GALLBLADDER DISORDER 78
430 MOUTH ULCERATION 78
431 PERIPHERAL VENOUS DISEASE 78
432 RESTLESS LEGS SYNDROME 78
433 STEVENS-JOHNSON SYNDROME 78
434 BLOOD PRESSURE ABNORMAL 77
435 LIVER FUNCTION TEST INCREASED 77
436 RENAL INJURY 77
437 WEIGHT FLUCTUATION 77
438 HEART RATE IRREGULAR 76
439 PHOTOPHOBIA 76
440 STAPHYLOCOCCAL INFECTION 76
441 VAGINAL HAEMORRHAGE 76
442 ACTIVITIES OF DAILY LIVING IMPAIRED 75
443 ANGIOEDEMA 75
444 BREAST CANCER STAGE III 75
445 REACTION TO DRUG EXCIPIENTS 75
446 SLEEP APNOEA SYNDROME 75
447 BODY TEMPERATURE DECREASED 74
448 DEAFNESS 74
449 TENDONITIS 74
450 ANAPHYLACTIC SHOCK 73
451 APHASIA 73
452 BLOOD POTASSIUM DECREASED 73
453 DYSKINESIA 73
454 INJECTION SITE RASH 73
455 MUSCLE TIGHTNESS 73
456 TOOTH INFECTION 73
457 AGEUSIA 72
458 BACK DISORDER 72
459 DEVICE ISSUE 72
460 DIVERTICULITIS 72
461 FEBRILE NEUTROPENIA 72
462 FOOT FRACTURE 72
463 HAEMORRHOIDS 72
464 RESPIRATORY TRACT INFECTION 72
465 RESTLESSNESS 72
466 EMOTIONAL DISORDER 71
467 HEPATIC CIRRHOSIS 71
468 TREATMENT NONCOMPLIANCE 71
469 ABDOMINAL PAIN LOWER 70
470 ACUTE MYOCARDIAL INFARCTION 70
471 BLOOD PRESSURE DIASTOLIC ABNORMAL 70
472 CONJUNCTIVITIS 70
473 INJECTION SITE MASS 70
474 LOCAL SWELLING 70
475 PHOTOSENSITIVITY REACTION 70
476 PROCEDURAL PAIN 70
477 PRODUCT COLOUR ISSUE 70
478 PRODUCT LABEL ISSUE 70
479 ABASIA 69
480 HIP FRACTURE 69
481 MELAENA 69
482 NEOPLASM PROGRESSION 69
483 PRESYNCOPE 69
484 ULCER HAEMORRHAGE 69
485 BLOOD PRESSURE SYSTOLIC ABNORMAL 68
486 COLITIS 68
487 DISABILITY 68
488 EATING DISORDER 68
489 GASTROENTERITIS VIRAL 68
490 HAEMOPTYSIS 68
491 SWOLLEN JOINT COUNT INCREASED 68
492 CARPAL TUNNEL SYNDROME 67
493 HYPERLIPIDAEMIA 67
494 INTESTINAL OBSTRUCTION 67
495 MOOD ALTERED 67
496 PARAESTHESIA ORAL 67
497 PRODUCT DOSE OMISSION IN ERROR 67
498 UPPER GASTROINTESTINAL HAEMORRHAGE 67
499 CONGENITAL ANOMALY 66
500 HIP ARTHROPLASTY 66
501 MUSCLE SPASTICITY 66
502 RED BLOOD CELL SEDIMENTATION RATE INCREASED 66
503 SINUS CONGESTION 66
504 BLOOD PRESSURE DIASTOLIC DECREASED 65
505 DYSMENORRHOEA 65
506 HIATUS HERNIA 65
507 HYPERGLYCAEMIA 65
508 INTENTIONAL DOSE OMISSION 65
509 KNEE ARTHROPLASTY 65
510 MUSCLE TWITCHING 65
511 NERVE COMPRESSION 65
512 SKIN FISSURES 65
513 TASTE DISORDER 65
514 THINKING ABNORMAL 65
515 ABNORMAL BEHAVIOUR 64
516 LEUKOPENIA 64
517 NEOPLASM MALIGNANT 64
518 TOXIC EPIDERMAL NECROLYSIS 64
519 DERMATITIS ATOPIC 63
520 KIDNEY INFECTION 63
521 SKIN LESION 63
522 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 62
523 ANKLE FRACTURE 62
524 BREAST CANCER 62
525 HYPOXIA 62
526 JOINT DISLOCATION 62
527 PULMONARY OEDEMA 62
528 HAEMATOCRIT DECREASED 61
529 PRODUCT DIFFICULT TO SWALLOW 61
530 DISLOCATION OF VERTEBRA 60
531 GASTRIC ULCER HAEMORRHAGE 60
532 HAEMATURIA 60
533 INJECTION SITE URTICARIA 60
534 PHARYNGITIS STREPTOCOCCAL 60
535 RESPIRATORY TRACT CONGESTION 60
536 ROTATOR CUFF SYNDROME 60
537 BLOOD ALKALINE PHOSPHATASE INCREASED 59
538 BLOOD BILIRUBIN INCREASED 59
539 BONE EROSION 59
540 LIVER FUNCTION TEST ABNORMAL 59
541 PELVIC PAIN 59
542 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 58
543 MUSCLE STRAIN 58
544 AGGRESSION 57
545 DEPRESSED LEVEL OF CONSCIOUSNESS 57
546 FOETAL EXPOSURE DURING PREGNANCY 57
547 FOREIGN BODY IN THROAT 57
548 INFUSION SITE PAIN 57
549 LYMPHOCYTE COUNT DECREASED 57
550 PRODUCT STORAGE ERROR 57
551 SPINAL OSTEOARTHRITIS 57
552 THERAPEUTIC PRODUCT EFFECT VARIABLE 57
553 FEEDING DISORDER 56
554 FOREIGN BODY IN RESPIRATORY TRACT 56
555 HEPATIC STEATOSIS 56
556 TENDERNESS 56
557 TUBULOINTERSTITIAL NEPHRITIS 56
558 ABSCESS 55
559 BLOOD PRESSURE DIASTOLIC INCREASED 55
560 DRUG ADMINISTRATION ERROR 55
561 INCORRECT DRUG ADMINISTRATION DURATION 55
562 MENORRHAGIA 55
563 OSTEOPENIA 55
564 SKIN LACERATION 55
565 APHONIA 54
566 ARRHYTHMIA 54
567 BRADYCARDIA 54
568 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 54
569 GINGIVAL BLEEDING 54
570 HEPATIC FAILURE 54
571 HERNIA 54
572 HYPOPHAGIA 54
573 PNEUMONITIS 54
574 PRODUCT FORMULATION ISSUE 54
575 PULMONARY FIBROSIS 54
576 TENDON DISORDER 54
577 BACK INJURY 53
578 BODY TEMPERATURE INCREASED 53
579 DRUG-INDUCED LIVER INJURY 53
580 EYELID OEDEMA 53
581 GOUT 53
582 HEMIPARESIS 53
583 MENTAL IMPAIRMENT 53
584 PALLOR 53
585 RETINITIS 53
586 SENSORY DISTURBANCE 53
587 THERAPEUTIC PRODUCT EFFECT DELAYED 53
588 COLD SWEAT 52
589 DIVERTICULUM 52
590 INITIAL INSOMNIA 52
591 LIGAMENT SPRAIN 52
592 LUPUS-LIKE SYNDROME 52
593 MICTURITION URGENCY 52
594 NEUTROPHIL COUNT DECREASED 52
595 RENAL PAIN 52
596 SKIN ULCER 52
597 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 52
598 SPINAL PAIN 52
599 BRAIN FOG 51
600 IMPAIRED DRIVING ABILITY 51
601 INSURANCE ISSUE 51
602 MULTIPLE ALLERGIES 51
603 PAIN OF SKIN 51
604 PHARYNGITIS 51
605 SARS-COV-2 TEST POSITIVE 51
606 SENSATION OF FOREIGN BODY 51
607 COMA 50
608 ERUCTATION 50
609 INFLAMMATORY BOWEL DISEASE 50
610 OSTEOMYELITIS 50
611 SEPTIC SHOCK 50
612 THIRST 50
613 CARDIAC ARREST 49
614 DRUG ABUSE 49
615 EPIGASTRIC DISCOMFORT 49
616 MENTAL STATUS CHANGES 49
617 RESPIRATORY DISTRESS 49
618 BASAL CELL CARCINOMA 48
619 INCREASED APPETITE 48
620 PREGNANCY 48
621 VITAMIN D DECREASED 48
622 BLINDNESS UNILATERAL 47
623 BLOOD SODIUM DECREASED 47
624 CENTRAL NERVOUS SYSTEM LESION 47
625 DERMATITIS CONTACT 47
626 END STAGE RENAL DISEASE 47
627 ERECTILE DYSFUNCTION 47
628 HAIR TEXTURE ABNORMAL 47
629 HYPOKINESIA 47
630 LEUKOCYTOSIS 47
631 MITRAL VALVE INCOMPETENCE 47
632 NERVOUS SYSTEM DISORDER 47
633 OSTEONECROSIS OF JAW 47
634 PRESCRIBED UNDERDOSE 47
635 UPPER LIMB FRACTURE 47
636 VISUAL ACUITY REDUCED 47
637 WALKING AID USER 47
638 ASCITES 46
639 BLOOD TEST ABNORMAL 46
640 DEVICE DISLOCATION 46
641 FACE OEDEMA 46
642 GASTROINTESTINAL PAIN 46
643 MASS 46
644 METABOLIC ACIDOSIS 46
645 METASTASES TO BONE 46
646 METRORRHAGIA 46
647 PANCREATITIS ACUTE 46
648 PANCYTOPENIA 46
649 PRODUCT PACKAGING ISSUE 46
650 SCAB 46
651 SECRETION DISCHARGE 46
652 CEREBRAL HAEMORRHAGE 45
653 DENTAL CARIES 45
654 FACIAL PAIN 45
655 IRON DEFICIENCY ANAEMIA 45
656 OESOPHAGEAL PAIN 45
657 PERIPHERAL COLDNESS 45
658 SYNOVIAL CYST 45
659 TEMPERATURE INTOLERANCE 45
660 UVEITIS 45
661 X-RAY ABNORMAL 45
662 BEDRIDDEN 44
663 CARDIOMEGALY 44
664 COORDINATION ABNORMAL 44
665 EXPIRED DRUG ADMINISTERED 44
666 JAUNDICE 44
667 PRODUCT ADMINISTRATION ERROR 44
668 THERMAL BURN 44
669 BLOOD GLUCOSE DECREASED 43
670 CYST 43
671 DEVICE MALFUNCTION 43
672 EYE INFECTION 43
673 GASTROENTERITIS 43
674 GLAUCOMA 43
675 MENSTRUATION IRREGULAR 43
676 OVARIAN CYST 43
677 PLASMA CELL MYELOMA 43
678 TOOTH FRACTURE 43
679 VITAMIN D DEFICIENCY 43
680 BONE DENSITY DECREASED 42
681 DERMATITIS 42
682 HAIR COLOUR CHANGES 42
683 IMMUNODEFICIENCY 42
684 INJECTION SITE WARMTH 42
685 TONGUE DISCOMFORT 42
686 BLOOD CALCIUM DECREASED 41
687 BLOOD IRON DECREASED 41
688 BLOOD TRIGLYCERIDES INCREASED 41
689 C-REACTIVE PROTEIN 41
690 DUODENAL ULCER 41
691 EYE HAEMORRHAGE 41
692 FRUSTRATION TOLERANCE DECREASED 41
693 INCREASED TENDENCY TO BRUISE 41
694 TOOTH ABSCESS 41
695 BACTERIAL INFECTION 40
696 DECREASED INTEREST 40
697 DRY THROAT 40
698 EAR DISCOMFORT 40
699 HUNGER 40
700 OESOPHAGITIS 40
701 POST-TRAUMATIC STRESS DISORDER 40
702 QUALITY OF LIFE DECREASED 40
703 SPINAL FRACTURE 40
704 ANOSMIA 39
705 ATELECTASIS 39
706 GAMMA-GLUTAMYLTRANSFERASE INCREASED 39
707 INCONTINENCE 39
708 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 39
709 SKIN CANCER 39
710 BREAST PAIN 38
711 CHOLECYSTITIS 38
712 DEMENTIA 38
713 FEELING OF BODY TEMPERATURE CHANGE 38
714 FULL BLOOD COUNT DECREASED 38
715 IMPAIRED GASTRIC EMPTYING 38
716 INTENTIONAL DRUG MISUSE 38
717 OROPHARYNGEAL DISCOMFORT 38
718 PARANOIA 38
719 RENAL TUBULAR NECROSIS 38
720 THROMBOPHLEBITIS SUPERFICIAL 38
721 ABORTION SPONTANEOUS 37
722 CANDIDA INFECTION 37
723 CORONARY ARTERY OCCLUSION 37
724 DEFAECATION URGENCY 37
725 INTERNAL HAEMORRHAGE 37
726 ORAL CANDIDIASIS 37
727 PAROSMIA 37
728 PRODUCT AVAILABILITY ISSUE 37
729 RASH MACULO-PAPULAR 37
730 SKIN HAEMORRHAGE 37
731 THYROID DISORDER 37
732 UPPER-AIRWAY COUGH SYNDROME 37
733 WRONG DRUG ADMINISTERED 37
734 ACUTE RESPIRATORY FAILURE 36
735 APHTHOUS ULCER 36
736 ARTHROPOD BITE 36
737 BRONCHOSPASM 36
738 CORONARY ARTERY STENOSIS 36
739 DRUG SCREEN POSITIVE 36
740 FEELING DRUNK 36
741 GINGIVAL PAIN 36
742 HAEMATOMA 36
743 MADAROSIS 36
744 PHARMACEUTICAL PRODUCT COMPLAINT 36
745 PSYCHOMOTOR HYPERACTIVITY 36
746 PULMONARY MASS 36
747 ROSACEA 36
748 BLOOD COUNT ABNORMAL 35
749 CARDIOVASCULAR DISORDER 35
750 CHOLECYSTECTOMY 35
751 CLOSTRIDIUM DIFFICILE INFECTION 35
752 EAR DISORDER 35
753 EPILEPSY 35
754 IMMUNE SYSTEM DISORDER 35
755 INJECTION SITE INDURATION 35
756 MUSCLE ATROPHY 35
757 NASAL DISCOMFORT 35
758 POST PROCEDURAL COMPLICATION 35
759 RHABDOMYOLYSIS 35
760 SLUGGISHNESS 35
761 UTERINE LEIOMYOMA 35
762 ANOREXIA 34
763 APATHY 34
764 BLOOD DISORDER 34
765 BOWEL MOVEMENT IRREGULARITY 34
766 CARDIAC FAILURE 34
767 CARDIAC MURMUR 34
768 CEREBRAL INFARCTION 34
769 DECREASED ACTIVITY 34
770 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 34
771 NERVE INJURY 34
772 ODYNOPHAGIA 34
773 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 34
774 PLATELET COUNT INCREASED 34
775 PULMONARY CONGESTION 34
776 TONGUE DISORDER 34
777 VITREOUS FLOATERS 34
778 APPLICATION SITE PAIN 33
779 FLANK PAIN 33
780 GINGIVITIS 33
781 HALLUCINATION, VISUAL 33
782 HYPOGLYCAEMIA 33
783 INFUSION SITE ERYTHEMA 33
784 LACERATION 33
785 LUNG NEOPLASM MALIGNANT 33
786 LUPUS VULGARIS 33
787 PNEUMONIA ASPIRATION 33
788 SWOLLEN JOINT COUNT 33
789 TOOTH EXTRACTION 33
790 BLADDER DISORDER 32
791 BLOOD UREA INCREASED 32
792 CARDIO-RESPIRATORY ARREST 32
793 COMPLETED SUICIDE 32
794 DRUG TOXICITY 32
795 ECONOMIC PROBLEM 32
796 IMPAIRED QUALITY OF LIFE 32
797 JOINT EFFUSION 32
798 MUSCLE DISORDER 32
799 OCULAR DISCOMFORT 32
800 ORAL DISORDER 32
801 PANIC REACTION 32
802 PARANASAL SINUS DISCOMFORT 32
803 PROSTATE CANCER 32
804 SENSORY LOSS 32
805 SINUS HEADACHE 32
806 TENSION HEADACHE 32
807 TRICUSPID VALVE INCOMPETENCE 32
808 VENTRICULAR EXTRASYSTOLES 32
809 VITAMIN B12 DECREASED 32
810 WRIST FRACTURE 32
811 BILIARY DYSKINESIA 31
812 BLOOD CALCIUM INCREASED 31
813 DIZZINESS POSTURAL 31
814 HANGOVER 31
815 NAIL DISORDER 31
816 PARALYSIS 31
817 PSYCHOTIC DISORDER 31
818 TOOTH LOSS 31
819 ACCIDENT 30
820 CHEILITIS 30
821 DRUG TOLERANCE 30
822 ENERGY INCREASED 30
823 EYE DISCHARGE 30
824 HYSTERECTOMY 30
825 INCORRECT PRODUCT ADMINISTRATION DURATION 30
826 INCREASED UPPER AIRWAY SECRETION 30
827 LIBIDO DECREASED 30
828 LYMPHOEDEMA 30
829 MAJOR DEPRESSION 30
830 MOUTH SWELLING 30
831 NASAL DRYNESS 30
832 NODULE 30
833 OSTEONECROSIS 30
834 PHARYNGEAL SWELLING 30
835 PRODUCT COMMINGLING 30
836 RHINITIS 30
837 SENSITIVITY TO WEATHER CHANGE 30
838 SINUS TACHYCARDIA 30
839 SMALL INTESTINAL OBSTRUCTION 30
840 TENDON RUPTURE 30
841 VISUAL DISTURBANCE 30
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 29
843 DIARRHOEA HAEMORRHAGIC 29
844 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 29
845 EUPHORIC MOOD 29
846 FOOD ALLERGY 29
847 HAIR DISORDER 29
848 INFLAMMATORY MARKER INCREASED 29
849 LUNG INFECTION 29
850 NEPHROPATHY 29
851 NOCTURIA 29
852 PERICARDIAL EFFUSION 29
853 PERONEAL NERVE PALSY 29
854 PORPHYRIA ACUTE 29
855 SPINAL OPERATION 29
856 SPLENOMEGALY 29
857 SPUTUM DISCOLOURED 29
858 ATRIAL SEPTAL DEFECT 28
859 BLOOD LACTATE DEHYDROGENASE INCREASED 28
860 CONCUSSION 28
861 DELUSION 28
862 DEVICE BREAKAGE 28
863 DEVICE DIFFICULT TO USE 28
864 HYPERKALAEMIA 28
865 MALNUTRITION 28
866 MATERNAL EXPOSURE TIMING UNSPECIFIED 28
867 MELANOCYTIC NAEVUS 28
868 NEPHROGENIC ANAEMIA 28
869 PIGMENTATION DISORDER 28
870 PLANTAR FASCIITIS 28
871 PNEUMOTHORAX 28
872 SNORING 28
873 SPINAL DISORDER 28
874 SQUAMOUS CELL CARCINOMA 28
875 SUNBURN 28
876 VAGINAL DISCHARGE 28
877 ACUTE RESPIRATORY DISTRESS SYNDROME 27
878 ADVERSE REACTION 27
879 BLINDNESS TRANSIENT 27
880 BLOOD MAGNESIUM DECREASED 27
881 BONE LOSS 27
882 CARDIAC FLUTTER 27
883 CHOKING SENSATION 27
884 CHOLESTASIS 27
885 DRUG EXPOSURE DURING PREGNANCY 27
886 EYELID PTOSIS 27
887 FISTULA 27
888 GRIP STRENGTH 27
889 HYPERAESTHESIA 27
890 INJECTION SITE INFLAMMATION 27
891 INTERNATIONAL NORMALISED RATIO INCREASED 27
892 ISCHAEMIC STROKE 27
893 LIVE BIRTH 27
894 MACULAR DEGENERATION 27
895 MUCOSAL INFLAMMATION 27
896 OPTIC NEURITIS 27
897 PRODUCT ADHESION ISSUE 27
898 PRODUCT PRESCRIBING ERROR 27
899 PRODUCT SHAPE ISSUE 27
900 SCOLIOSIS 27
901 UNRESPONSIVE TO STIMULI 27
902 ANAL INCONTINENCE 26
903 AORTIC VALVE INCOMPETENCE 26
904 ATAXIA 26
905 CARTILAGE INJURY 26
906 DYSGRAPHIA 26
907 ENCEPHALOPATHY 26
908 GENERAL SYMPTOM 26
909 HEARING IMPAIRED 26
910 HEPATOTOXICITY 26
911 JAW DISORDER 26
912 MANIA 26
913 MENISCUS INJURY 26
914 MENSTRUAL DISORDER 26
915 MYDRIASIS 26
916 OESOPHAGEAL DISORDER 26
917 SUPRAVENTRICULAR TACHYCARDIA 26
918 THERAPY CHANGE 26
919 TRANSAMINASES INCREASED 26
920 VASCULITIS 26
921 APPLICATION SITE PRURITUS 25
922 COAGULOPATHY 25
923 COLON CANCER 25
924 DRUG TOLERANCE DECREASED 25
925 GENERALISED OEDEMA 25
926 GROIN PAIN 25
927 HEART RATE ABNORMAL 25
928 INJECTION SITE DISCOMFORT 25
929 KNEE OPERATION 25
930 LOWER GASTROINTESTINAL HAEMORRHAGE 25
931 LUNG INFILTRATION 25
932 MENOPAUSAL SYMPTOMS 25
933 MOUTH HAEMORRHAGE 25
934 PARKINSON^S DISEASE 25
935 POOR VENOUS ACCESS 25
936 PREMATURE BABY 25
937 PROCTALGIA 25
938 PRODUCT ADMINISTRATION INTERRUPTED 25
939 PRODUCT USED FOR UNKNOWN INDICATION 25
940 SKIN INFECTION 25
941 SKIN WARM 25
942 SPONDYLITIS 25
943 STREPTOCOCCAL INFECTION 25
944 SUSPECTED COUNTERFEIT PRODUCT 25
945 TENDON PAIN 25
946 THERAPEUTIC RESPONSE CHANGED 25
947 TOXIC SKIN ERUPTION 25
948 URINE ODOUR ABNORMAL 25
949 WRONG PRODUCT ADMINISTERED 25
950 CYANOSIS 24
951 CYTOLYTIC HEPATITIS 24
952 EYE INFLAMMATION 24
953 GENERALISED ERYTHEMA 24
954 HEPATIC PAIN 24
955 INFUSION SITE PRURITUS 24
956 INFUSION SITE SWELLING 24
957 MUSCLE FATIGUE 24
958 NEUTROPHIL COUNT INCREASED 24
959 RESPIRATORY RATE INCREASED 24
960 SCRATCH 24
961 SPINAL COMPRESSION FRACTURE 24
962 ANGINA UNSTABLE 23
963 ARTERIAL OCCLUSIVE DISEASE 23
964 BLOOD ALBUMIN DECREASED 23
965 BLOOD POTASSIUM INCREASED 23
966 BONE LESION 23
967 CHAPPED LIPS 23
968 DERMATITIS ALLERGIC 23
969 DRUG LEVEL INCREASED 23
970 FOOD POISONING 23
971 FULL BLOOD COUNT ABNORMAL 23
972 GASTRITIS EROSIVE 23
973 GASTROINTESTINAL INFECTION 23
974 GOITRE 23
975 HEPATIC FUNCTION ABNORMAL 23
976 HYDROCEPHALUS 23
977 INJECTION SITE DISCOLOURATION 23
978 LOW DENSITY LIPOPROTEIN INCREASED 23
979 METASTASES TO LIVER 23
980 OBSESSIVE-COMPULSIVE DISORDER 23
981 PERIORBITAL SWELLING 23
982 PULMONARY HYPERTENSION 23
983 REACTION TO EXCIPIENT 23
984 RENAL CYST 23
985 RESPIRATION ABNORMAL 23
986 SOMNAMBULISM 23
987 TRISMUS 23
988 AMENORRHOEA 22
989 APPENDICITIS 22
990 APPLICATION SITE ERYTHEMA 22
991 ARTERIOSCLEROSIS 22
992 BLADDER CANCER 22
993 BLEPHAROSPASM 22
994 CARDIOMYOPATHY 22
995 DEPENDENCE 22
996 EMPHYSEMA 22
997 EXPOSURE VIA SKIN CONTACT 22
998 FEAR OF DISEASE 22
999 FEMUR FRACTURE 22